Biochemical aspects of neurodegeneration in human brain: Involvement of neural membrane phospholipids and phospholipases A 2

Neurochemical Research

Volumn 29, Issue 11 SPEC. ISS., 2004, Pages 1961-1977

  Farooqui, Akhlaq A ^a   Ong, Wei Yi ^b   Horrocks, Lloyd A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

apoptosis; calcium influx; necrosis; neurodegeneration; oxidative stress; Phospholipases

Indexed keywords

ALPHA TOCOPHEROL; ANTIMALARIAL AGENT; ARACHIDONIC ACID; CITICOLINE; DIACYLGLYCEROL; ENZYME; ICOSANOID; LIPID PEROXIDE; MEMBRANE PHOSPHOLIPID; MEPACRINE; PHOSPHOLIPASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE C; PHOSPHOLIPASE D; THROMBOCYTE ACTIVATING FACTOR;

ALZHEIMER DISEASE; APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN; CALCIUM TRANSPORT; CELL MEMBRANE FLUIDITY; DEGENERATIVE DISEASE; ENERGY METABOLISM; HEAD INJURY; HOMEOSTASIS; HUMAN; HYDROLYSIS; ISCHEMIA; LIPID STORAGE; MEMBRANE PERMEABILITY; METABOLITE; NECROSIS; NERVE CELL LESION; NERVE DEGENERATION; NERVE MEMBRANE; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SPINAL CORD INJURY; STIMULATION;

ANIMALS; BRAIN CHEMISTRY; HUMANS; ISOENZYMES; MEMBRANES; NEURODEGENERATIVE DISEASES; PHOSPHOLIPASES A; PHOSPHOLIPIDS;

EID: 3042539683     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-004-6871-3     Document Type: Review

References (134)

1. Farooqui, A. A., Farooqui, T., and Horrocks, L. A. 2002. Molecular species of phospholipids during brain development. Their occurrence, separation and roles. Pages 147-158, in Skinner, E. R. (ed.), Brain lipids and disorders in biological psychiatry. Amsterdam: Elsevier Science B.V.
2. Farooqui, A. A., Horrocks, L. A., and Farooqui, T. 2000. Glycerophospholipids in brain: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 106:1-29.
3. Voelker, D. R. 2003. New perspectives on the regulation of intermembrane glycerophospholipid traffic. J. Lipid Res. 44:441-449.
4. 2: Localization, role, and involvement in neurological diseases. Neuroscientist 6:169-180.
5. Horrocks, L. A., VanRollins, M., and Yates, A. J. 1981. Lipid changes in the ageing brain. Pages 601-630, in Davison, A. N. and Thompson, R. H. S. (eds.), The molecular basis of neuropathology. London: Edward Arnold Ltd.
6. Söderberg, M., Edlund, C., Kristensson, K., and Dallner, G. 1990. Lipid compositions of different regions of the human brain during aging. J. Neurochem. 54:415-423.
7. Söderberg, M., Edlund, C., Kristensson, K., and Dallner, G. 1991. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26:421-425.
8. Svennerholm, L., Boström, K., Helander, C. G., and Jungbjer, B. 1991. Membrane lipids in the aging human brain. J. Neurochem. 56:2051-2059.
9. Porcellati, G. 1983. Phospholipid metabolism in neural membranes. Pages 3-35, in Sun, G. Y., Bazan, N., Wu, J. Y., Porcellati, G., and Sun, A. Y. (eds.), Neural membranes. New York: Humana Press.
10. Bains, J. S. and Shaw, C. A. 1997. Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Rev. 25:335-358.
11. 2 from bovine brain cytosol. J. Neurochem. 59:708-714.
12. Rhee, S. G. and Bae, Y. S. 1997. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272:15045-15048.
13. 2 activity in human brain. J. Neurochem. 64:2213-2221.
14. Exton, J. H. 1997. New developments in phospholipase D. J. Biol. Chem. 272:15579-15582.
15. Banno, Y. 2002. Regulation and possible role of mammalian phospholipase D in cellular functions. J. Biochem. (Tokyo) 131:301-306.
16. Fukami, K. 2002. Structure, regulation, and function of phospholipase C isozymes. J. Biochem. (Tokyo) 131:293-299.
17. 2 and its role in brain tissue. J. Neurochem. 69:889-901.
18. 2 in neurodegeneration. Neurochem. Int. 30:517-522.
19. 2. J. Lipid Mediat. Cell Signal 12:83-117.
20. Klein, J., Chalifa, V., Liscovitch, M., and Löffelholz, K. 1995. Role of phospholipase D activation in nervous system physiology and pathophysiology. J. Neurochem. 65:1445-1455.
21. 2 activity: Their neurochemical effects and therapeutical importance for neurological disorders. Brain Res. Bull. 49:139-153.
22. 2. J. Biol. Chem. 272:16709-16712.
23. Farooqui, A. A., Rapoport, S. I., and Horrocks, L. A. 1997. Membrane phospholipid alterations in Alzheimer disease: Deficiency of ethanolamine plasmalogens. Neurochem. Res. 22:523-527.
24. Farooqui, A. A., Horrocks, L. A., and Farooqui, T. 2000. Deacylation and reacylation of neural membrane glycerophospholipids. J. Mol. Neurosci. 14:123-135.
25. Corbin, D. R. and Sun, G. Y. 1978. Characterization of the enzymic transfer of arachidonoyl groups to 1-acyl-phosphoglycerides in mouse synaptosome fraction. J. Neurochem. 30:77-82.
26. Sun, G. Y. and Su, K. L. 1979. Metabolism of arachidonoyl phosphoglycerides in mouse brain subcellular fractions. J. Neurochem. 32:1053-1059.
27. Rapoport, S. I. 1999. In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling. Neurochem. Res. 24:1403-1415.
28. Majno, G. and Joris, I. 1995. Apoptosis, oncosis, and necrosis: An overview of cell death. Am. J. Pathol. 146:3-15.
29. Sastry, P. S. and Rao, K. S. 2000. Apoptosis and the nervous system. J. Neurochem. 74:1-20.
30. Leist, M. and Nicotera, P. 1998. Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239:183-201.
31. Chen, J., Nagayama, T., Jin, K., Stetler, R. A., Zhu, R. L., Graham, S. H., and Simon, R. P. 1998. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18:4914-4928.
32. Springer, J. E., Azbill, R. D., and Knapp, P. E. 1999. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat. Med. 5:943-946.
33. McIntosh, T. K., Saatman, K. E., Raghupathi, R., Graham, D. I., Smith, D. H., Lee, V. M., and Trojanowski, J. Q. 1998. The molecular and cellular sequelae of experimental traumatic brain injury: Pathogenetic mechanisms. Neuropathol. Appl. Neurobiol. 24:251-267.
34. Su, J. H., Zhao, M., Anderson, A. J., Srinivasan, A., and Cotman, C. W. 2001. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res. 898:350-357.
35. Tamagno, E., Parola, M., Guglielmotto, M., Santoro, G., Bardini, P., Marra, L., Tabaton, M., and Danni, O. 2003. Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radic. Biol. Med. 35:45-58.
36. Rimon, G., Bazenet, C. E., Philpott, K. L., and Rubin, L. L. 1997. Increased surface phosphatidylserine is an early marker of neuronal apoptosis. J. Neurosci. Res. 48:563-570.
37. Williamson, P. and Schlegel, R. A. 2002. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1585:53-63.
38. Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A., and Henson, P. M. 2000. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405:85-90.
39. Emoto, K., Toyama-Sorimachi, N., Karasuyama, H., Inoue, K., and Umeda, M. 1997. Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp. Cell Res. 232:430-434.
40. Maulik, N., Kagan, V. E., Tyurin, V. A., and Das, D. K. 1998. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am. J. Physiol. Heart Circ. Physiol. 274:H242-H248.
41. 2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:5073-5077.
42. 2. Cell Death Differ. 6:890-901.
43. 2 which undergoes proteolytic inactivation. J. Biol. Chem. 273:13870-13877.
44. 2 augments spontaneous fatty acid release. J. Biol. Chem. 275:18248-18258.
45. Zhang, J., Hannun, Y. A., and Obeid, L. M. 1999. A novel assay for apoptotic body formation and membrane release during apoptosis. Cell Death Differ. 6:596-598.
46. Denecker, G., Vercammen, D., Declercq, W., and Vandenabeele, P. 2001. Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol. Life Sci. 58:356-370.
47. Fernandez, M. G., Troiano, L., Moretti, L., Nasi, M., Pinti, M., Salvioli, S., Dobrucki, J., and Cossarizza, A. 2002. Early changes in intramitochondrial cardiolipin distribution during apoptosis. Cell Growth Differ. 13:449-455.
48. McMillin, J. B. and Dowhan, W. 2002. Cardiolipin and apoptosis. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1585:97-107.
49. Singh, J. K., Dasgupta, A., Adayev, T., Shahmehdi, S. A., Hammond, D., and Banerjee, P. 1996. Apoptosis is associated with an increase in saturated fatty acid containing phospholipids in the neuronal cell line, HN2-5. Biochim. Biophys. Acta Lipids Lipid Metab. 1304:171-178.
50. 13C NMR-spectroscopy. Anticancer Res. 19:4027-4032.
51. Cui, Z. and Houweling, M. 2002. Phosphatidylcholine and cell death. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1585:87-96.
52. 2 and apoptosis. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1585:72-76.
53. 2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biochem. 268:11290-11295.
54. 2 and cyclooxygenase 2. Biochem. Biophys. Res. Commun. 220:681-686.
55. 2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosis. FEBS Lett. 379:77-81.
56. 2 activity in the outgrowth of adult mouse sensory axons in vitro. Neuroscience 91:1539-1547.
57. Vanags, D. M., Larsson, P., Feltenmark, S., Jakobsson, P. J., Orrenius, S., Claesson, H. E., and Aguilar-Santelises, M. 1997. Inhibitors of arachidonic acid metabolism reduce DNA and nuclear fragmentation induced by TNF plus cycloheximide in U937 cells. Cell Death Differ. 4:479-486.
58. Robinson, B. S., Hii, C. S. T., Poulos, A., and Ferrante, A. 1997. Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids. Immunology 91:274-280.
59. 2 activation through a mechanism related to the phospholipase C-initiated signaling pathway in rabbit platelets. J. Biochem. (Tokyo) 125:96-102.
60. Lauber, K., Bohn, E., Krober, S. M., Xiao, Y. J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., Xu, Y., Autenrieth, I. B., Schulze-Osthoff, K., Belka, C., Stuhler, G., and Wesselborg, S. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717-730.
61. Latorre, E., Collado, M. P., Fernández, I., Aragonés, M. D., and Catalán, R. E. 2003. Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide. Eur. J. Biochem. 270:36-46.
62. 2 induces neuronal cell death via apoptosis. J. Neurochem. 81:449-461.
63. 2 induces apoptosis via a mechanism involving ceramide generation. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1581:75-88.
64. Wullner, U., Seyfried, J., Groscurth, P., Beinroth, S., Winter, S., Gleichmann, M., Heneka, M., Loschmann, P., Schulz, J. B., Weller, M., and Klockgether, T. 1999. Glutathione depletion and neuronal cell death: The role of reactive oxygen intermediates and mitochondrial function. Brain Res. 826:53-62.
65. Camandola, S., Poli, G., and Mattson, M. P. 2000. The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons. J. Neurochem. 74:159-168.
66. 2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp. Neurol. 180:144-155.
67. Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., and Mattson, M. P. 1997. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J. Neurochem. 68:255-264.
68. Zaleska, M. M. and Wilson, D. F. 1989. Lipid hydroperoxides inhibit reacylation of phospholipids in neuronal membranes. J. Neurochem. 52:255-260.
69. Higuchi, Y. and Yoshimoto, T. 2002. Arachidonic acid converts the glutathione depletion-induced apoptosis to necrosis by promoting lipid peroxidation and reducing caspase-3 activity in rat glioma cells. Arch. Biochem. Biophys. 400:133-140.
70. Farooqui, A. A. and Horrocks, L. A. 1994. Excitotoxicity and neurological disorders: Involvement of membrane phospholipids. Int. Rev. Neurobiol. 36:267-323.
71. Nitsch, R. M., Blusztajn, J. K., Pittas, A. G., Slack, B. E., Growdon, J. H., and Wurtman, R. J. 1992. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA 89:1671-1675.
72. Wells, K., Farooqui, A. A., Liss, L., and Horrocks, L. A. 1995. Neural membrane phospholipids in Alzheimer disease. Neurochem. Res. 20:1329-1333.
73. Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H., and Markesbery, W. R. 1998. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23:81-88.
74. Guan, Z. Z., Wang, Y. A., Cairns, N. J., Lantos, P. L., Dallner, G., and Sindelar, P. J. 1999. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J. Neuropathol. Exp. Neurol. 58:740-747.
75. Han, X. L., Holtzman, D. M., and McKeel, D. W., Jr. 2001. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: Molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77:1168-1180.
76. Pettegrew, J. W., Panchalingam, K., Hamilton, R. L., and McClure, R. J. 2001. Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 26:771-782.
77. Stokes, C. E. and Hawthorne, J. N. 1987. Reduced phosphoinositide concentration in anterior temporal cortex of Alzheimer's diseased brains. J. Neurochem. 48:1018-1021.
78. Söderberg, M., Edlund, C., Alafuzoff, I., Kristensson, K., and Dallner, G. 1992. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J. Neurochem. 59:1646-1653.
79. Conquer, J. A., Tierney, M. C., Zecevic, J., Bettger, W. J., and Fisher, R. H. 2000. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35:1305-1312.
80. Kyle, D. J., Schäfer, E., Patton, G., and Beiser, A. 1999. Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia. Lipids 34 Suppl:S245.
81. 2, and docosahexaenoic acid turnover in brain tissue. J. Mol. Neurosci. 16:263-272.
82. Tully, A. M., Roche, H. M., Doyle, R., Fallon, C., Bruce, I., Lawlor, B., Coakley, D., and Gibney, M. J. 2003. Low serum cholesteryl ester- docosahexaenoic acid levels in Alzheimer's disease: A case-control study. Br. J. Nutr. 89:483-489.
83. Terano, T., Fujishiro, S., Ban, T., Yamamoto, K., Tanaka, T., Noguchi, Y., Tamura, Y., Yazawa, K., and Hirayama, T. 1999. Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids 34 Suppl:S345-S346.
84. Farooqui, A. A., Ong, W. Y., and Horrocks, L. A. 2003. Plasmalogens, docosahexaenoic acid, and neurological disorders. Pages 335-354, in Roels, F., Baes, M., and de Bies, S. (eds.), Peroxisomal disorders and regulation of genes. London: Kluwer Academic/Plenum Publishers.
85. 2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis. 3:51-63.
86. 2 is induced in reactive glia following different forms of neurodegeneration. Glia 27:110-128.
87. Farooqui, A. A., Ong, W. Y., and Horrocks, L. A. 2003. Stimulation of lipases and phospholipases in Alzheimer disease. Pages 14-29, in Szuhaj, B. and van Nieuwenhuyzen, W. (eds.), Nutrition and biochemistry of phospholipids. Champaign: AOCS Press.
88. Pettegrew, J. W. 1989. Molecular insights into Alzheimer disease. Ann. N. Y. Acad. Sci. 568:5-28.
89. Pettegrew, J. W., Klunk, W. E., Kanal, E., Panchalingam, K., and McClure, R. J. 1995. Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia. Neurobiol. Aging 16:973-975.
90. Bazan, N. G. 1970. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim. Biophys. Acta 218:1-10.
91. Viani, P., Zini, I., Cervato, G., Biagini, G., Agnati, L. F., and Cestaro, B. 1995. Effect of endothelin-1 induced ischemia on peroxidative damage and membrane properties in rat striatum synaptosomes. Neurochem. Res. 20:689-695.
92. 2 in brain during ischemia. J. Neurochem. 39:1111-1116.
93. 2) activity in gerbil brain: Enhanced activities of cytosolic, mitochondrial, and microsomal forms after ischemia and reperfusion. J. Neurosci. 11:1829-1836.
94. 2 after transient global forebrain ischemia in the rat. Stroke 27:527-535.
95. 2 inhibitors in kainic acid induced neurodegeneration. Curr. Drug Targets - Cardiovasc. & Haematol. Disorders 4:85-96.
96. 2 in ischemic and toxic brain injury. Neurochem. Res. 25:745-753.
97. 2. Nature 390:622-625.
98. Geddes, J. W., Ulas, J., Brunner, L. C., Choe, W., and Cotman, C. W. 1992. Hippocampal excitatory amino acid receptors in elderly, normal individuals and those with Alzheimer's disease: Non-N-methyl-D-aspartate receptors. Neuroscience 50:23-34.
99. Beattie, M. S., Farooqui, A. A., and Bresnahan, J. C. 2000. Review of current evidence for apoptosis after spinal cord injury. J. Neurotrauma 17:915-925.
100. Demediuk, P., Saunders, R. D., Anderson, D. K., Means, E. D., and Horrocks, L. A. 1985. Membrane lipid changes in laminectomized and traumatized cat spinal cord. Proc. Natl. Acad. Sci. USA 82:7071-7075.
101. Anderson, D. K., Saunders, R. D., Demediuk, P., Dugan, L. L., Braughler, J. M., Hall, E. D., Means, E. D., and Horrocks, L. A. 1985. Lipid hydrolysis and peroxidation in injured spinal cord: Partial protection with methylprednisolone or vitamin E and selenium. Cent. Nerv. Syst. Trauma 2:257-267.
102. Taylor, W. A. 1988. Effects of impact injury of rat spinal cord on activities of some enzymes of lipid hydrolysis. Dissertation. Ohio State University, Columbus, Ohio.
103. Horrocks, L. A., Demediuk, P., Saunders, R. D., Dugan, L., Clendenon, N. R., Means, E. D., and Anderson, D. K. 1985. The degradation of phospholipids, formation of metabolites of arachidonic acid, and demyelination following experimental spinal cord injury. Cent. Nerv. Syst. Trauma 2:115-120.
104. Lukacova, N., Halat, G., Chavko, M., and Marsala, J. 1996. Ischemia-reperfusion injury in the spinal cord of rabbits strongly enhances lipid peroxidation and modifies phospholipid profiles. Neurochem. Res. 21:869-873.
105. 2 is activated after experimental closed head injury in the rat. J. Neurochem. 53:1541-1546.
106. Wei, E. P., Lamb, R. G., and Kontos, H. A. 1982. Increased phospholipase C activity after experimental brain injury. J. Neurosurg. 56:695-698.
107. Dhillon, H. S., Donaldson, D., Dempsey, R. J., and Prasad, M. R. 1994. Regional levels of free fatty acids and Evans blue extravasation after experimental brain injury. J. Neurotrauma 11:405-415.
108. Homayoun, P., Rodriguez de Turco, E. B., Parkins, N. E., Lane, D. C., Soblosky, J., Carey, M. E., and Bazan, N. G. 1997. Delayed phospholipid degradation in rat brain after traumatic brain injury. J. Neurochem. 69:199-205.
109. 2 inhibitors as therapeutic agents for neural cell injury. Curr. Med. Chem. Anti-Inflammatory & Anti-Allergy Agents 1:193-204.
110. 2 and neuronal death after intracerebroventricular carrageenan injection and neuroprotective effects of quinacrine. Exp. Neurol. 183:449-457.
111. 2 mRNA levels in the rat hippocampus after kainate-induced neuronal injury. Exp. Brain Res. 148:521-524.
112. Korth, C., May, B. C., Cohen, F. E., and Prusiner, S. B. 2001. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. USA 98:9836-9841.
113. Stewart, L. R., White, A. R., Jobling, M. F., Needham, B. E., Maher, F., Thyer, J., Beyreuther, K., Masters, C. L., Collins, S. J., and Cappai, R. 2001. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126. J. Neurosci. Res. 65:565-572.
114. 2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion. Brain Res. 752:203-208.
115. 2 inhibitors on kainate-induced neuronal injury in rat hippocampal slices. Free Radic. Biol. Med. 30:1263-1273.
116. 2. Eur. J. Pharmacol. 326:237-250.
117. 2. Biochim. Biophys. Acta 876:639-645.
118. Pentland, A. P., Morrison, A. R., Jacobs, S. C., Hruza, L. L., Hebert, J. S., and Packer, L. 1992. Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition. J. Biol. Chem. 267:15578-15584.
119. Tagami, M., Ikeda, K., Yamagata, K., Nara, Y., Fujino, H., Kubota, A., Numano, F., and Yamori, Y. 1999. Vitamin E prevents apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. Lab. Invest. 79:609-615.
120. Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, D. W., Pfeiffer, E., Schneider, L. S., and Thal, L. J. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N. Engl. J. Med. 336:1216-1222.
121. Floyd, R. A. and Hensley, K. 2002. Oxidative stress in brain aging - Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23:795-807.
122. 2 from bovine brain. Biochem. Biophys. Res. Commun. 199:1158-1166.
123. Saito, M., Saito, M., Berg, M. J., Guidotti, A., and Marks, N. 1999. Gangliosides attenuate ethanol-induced apoptosis in rat cerebellar granule neurons. Neurochem. Res. 24:1107-1115.
124. Ferrari, G., Anderson, B. L., Stephens, R. M., Kaplan, D. R., and Greene, L. A. 1995. Prevention of apoptotic neuronal death by GM1 ganglioside. Involvement of Trk neurotrophin receptors. J. Biol. Chem. 270:3074-3080.
125. 1 ganglioside treatment of spontaneously hypertensive stroke prone rats. Exp. Neurol. 126:95-100.
126. Matsuoka, Y., Saito, M., LaFrancois, J., Saito, M., Gaynor, K., Olm, V., Wang, L. L., Casey, E., Lu, Y. F., Shiratori, C., Lemere, C., and Duff, K. 2003. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J. Neurosci. 23:29-33.
127. Geisler, F. H., Dorsey, F. C., and Coleman, W. P. 1991. Recovery of motor function after spinal-cord injury - A randomized, placebo-controlled trial with GM-1 ganglioside. N. Engl. J. Med. 324:1829-1887.
128. Adibhatla, R. M., Hatcher, J. F., and Dempsey, R. J. 2002. Citicoline: Neuroprotective mechanisms in cerebral ischemia. J. Neurochem. 80:12-23.
129. Andersen, M., Overgaard, K., Meden, P., and Boysen, G. 1999. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke 30:1464-1470.
130. Dempsey, R. J. and Rao, V. L. R. 2003. Cytidinediphosphocholine treatment to decrease traumatic brain injury-induced hippocampal neuronal death, cortical contusion volume, and neurological dysfunction in rats. J. Neurosurg. 98:867-873.
131. Mir, C., Clotet, J., Aledo, R., Durany, N., Argemi, J., Lozano, R., Cervos-Navarro, J., and Casals, N. 2003. CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons. J. Mol. Neurosci. 20:53-59.
132. Murphy, E. J. and Horrocks, L. A. 1993. CDPcholine, CDP-ethanolamine, lipid metabolism and disorders of the central nervous system. Pages 353-372, in Massarelli, R., Horrocks, L., Kanfer, J. N., and Löffelholz, K. (eds.), Phospholipids and signal transmission. Heidelberg: Springer-Verlag GmbH.
133. 2 and transglutaminase. J. Clin. Invest. 111:19-21.
134. 2 and C activation during ischemia. J. Neurochem. 61:1677-1684.